Andrea Clay

Andrea McGee serves as a key procurement professional responsible for managing complex acquisitions in advanced scientific and laboratory technology sectors. She plays a critical role in aligning agency requirements with market capabilities, ensuring compliance with federal acquisition regulations while supporting mission-critical research and diagnostic capabilities. Her portfolio primarily encompasses high-precision analytical instruments, in-vitro diagnostic substances, and specialized testing services, often requiring technical evaluation and risk mitigation due to the specialized nature of the equipment and biological materials involved. She works closely with technical stakeholders to define performance-based specifications and ensures acquisitions support long-term scientific infrastructure goals. McGee cultivates relationships with a diverse range of vendors, including manufacturers of analytical laboratory instrumentation, biotechnology R&D firms, and independent testing laboratories. Her contracting approach emphasizes competitive solicitation and vendor engagement, fostering partnerships with both large-scale producers and niche suppliers capable of meeting stringent technical and regulatory standards. She prioritizes transparent procurement processes and encourages vendor participation through clear solicitation language and pre-solicitation outreach, promoting fair and open competition. Her contracting patterns reflect a strong preference for open competition, with over 82% of awards issued without set-aside restrictions. However, she consistently supports small business participation, allocating approximately 17% of awards to total small business set-asides under FAR 19.5, with minimal but intentional use of service-disabled veteran-owned and 8(a) set-asides. This balanced approach demonstrates a commitment to socioeconomic goals without compromising mission readiness or technical integrity. McGee’s primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 811219 (Other Commercial and Industrial Machinery and Equipment Repair), with significant activity in in-vitro diagnostic manufacturing (325413) and biotechnology R&D (541714). Her expertise spans the lifecycle of scientific instrumentation—from calibration and maintenance to advanced diagnostic reagent procurement—making her a pivotal figure in advancing laboratory modernization and public health research capabilities.